Discover

BCAB
BioAtla, Inc.
3.69
2 x 3.50
1 x 4.13
bid
ask
+
0.00
0.00%
200 @ 04:00 PM
3.69 +0.00 (0.00%)
Ytd-87.00%
1y-78.04%
day range
3.12
52 week range
71.50
OpenPrev Close3.69LowHighMkt Cap4.65M
Vol0.00Avg Vol49.29KEPS-14.76P/E-0.25Forward P/E-0.42
Beta0.76Short Ratio3.70Inst. Own42.79%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg3.85200-d Avg17.541yr Est9.00
Income Statement
Operating Expenses9.31M
Research and Development Expense4.58M
Selling, General and Administrative Expense4.73M
Operating Income-9.31M
Net Income-6.34M
Net Income Common Stock-6.34M
Net Income Common Stock (USD)-6.34M
Consolidated Income-6.34M
Earnings per Basic Share-4.22
Earnings per Basic Share (USD)-4.22
Earnings per Diluted Share-4.22
Earning Before Interest & Taxes (EBIT)-6.34M
Earning Before Interest & Taxes (USD)-6.34M
Weighted Average Shares1.50M
Weighted Average Shares Diluted1.50M
Balance Sheet
Cash and Equivalents1.96M
Cash and Equivalents (USD)1.96M
Current Assets3.09M
Property, Plant & Equipment Net5.31M
Total Assets8.57M
Debt Current1.56M
Total Debt6.09M
Current Liabilities20.69M
Debt Non-Current4.54M
Total Liabilities45.88M
Accumulated Retained Earnings (Deficit)-551.99M
Shareholders Equity-37.31M
Shareholders Equity (USD)-37.31M
Assets Non-Current5.47M
Total Debt (USD)6.09M
Liabilities Non-Current25.18M
Trade and Non-Trade Payables19.13M
Cash Flow
Depreciation, Amortization & Accretion120.00K
Net Cash Flow from Financing110.00K
Net Cash Flow / Change in Cash & Cash Equivalents-5.16M
Issuance (Purchase) of Equity Shares124.00K
Net Cash Flow from Operations-5.27M
Share Based Compensation956.00K